Latest National Institute for Health and Clinical Excellence Stories
THE ever-rising drugs bill is one of the biggest headaches for NHS decisionmakers. With some brand-name drugs costing many times as much as a nearidentical formulation under a generic name, doctors have been encouraged to prescribe generics wherever possible.
THE boss of the NHS's drug approval body today called on local healthcare trusts to end Britain's postcode lottery row.
By Gavin Engelbrecht THE Government?s drugs approval agency warned last night it might not be able to meet a pledge to speed up decision-making on new treatments.
A Leading Welsh cancer specialist has condemned plans to prevent patients with advanced kidney cancer from getting specialised drug treatments.
PATIENTS may get independent advice on medicine too costly for the NHS so they can buy it privately.
By Jeremy Laurance Patients cannot rely on the NHS to save their lives if the cost of doing so is too great, the Government's medicines watchdog has ruled for the first time.
PATIENTS with rare cancers are being left to die because of a postcode lottery over who gets access to drugs, research out today suggests. A study from the Rarer Cancers Forum found wide variations across England in the number of patients granted access to medicines.
BRITAIN'S National Health Service comes under intense scrutiny, but it remains the envy of the world. The principle of free treatment for all is one which has stood proud since the NHS was created 60 years ago.
Patients with rare cancers are being left to die due to a postcode lottery over who gets access to drugs, research out today suggests. A study from the Rarer Cancers Forum found wide variations across England in the number of patients granted access to medicines.
COVENTRY health chiefs are supporting a draft decision to reject four new cancer drugs for patients with advanced kidney cancer. The National Institute for Health and Clinical Excellence (Nice) decided that sunitinib, bevacizumab, sorafenib and Torisel are not a cost-effective use of NHS cash.